By admin | Published:
September 5, 2007
September 5, 2007
Edmond Cronin
REFERENCE: Abstract 3506, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria
EDMOND CRONIN, Cork University Hospital
Study data that support banning smoking in public places were unveiled at the ESC congress by a team from Ireland. After the smoking ban in 2004, admissions for acute coronary syndromes dropped, and lead author Edmond Cronin explained the significance of his findings to Derek Thorne.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Posted in Cardiovascular | Tagged acute, cardiovascular, coronary, esc, findings, heart, journal, podcast, podcasting, smoking, study, syndrome |
By admin | Published:
September 5, 2007
September 5, 2007
Ian Graham
REFERENCE: 15:40 Sunday 2nd Sept CV Disease Prevention, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria
IAN GRAHAM, Trinity College, Dublin
Three key modifiable factors determine cardiovascular risk: blood pressure, lipid profile and smoking. That’s according to Ian Graham who summarized the latest European Society of Cardiology guidelines for preventing heart disease. Other factoirs including the metabolic syndrome, gender, body mass index and activity levels generally also involve the three master factors, and there are big benefits to be gained from modifying each of the key factors singly even when a patient can’t change one or more of them. Peter Goodwin discussed the new guidelines with Professor Ian Graham during the cardiology conference in Vienna.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
By admin | Published:
September 3, 2007
September 3, 2007
Hugh Tunstall-Pedoe
REFERENCE: Abstract 1075, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria
HUGH TUNSTALL-PEDOE, University of Dundee
New data presented at the ESC congress suggests that social deprivation should be considered when considering a cardiac risk score – not just smoking, blood pressure, HDL and cholesterol. Derek Thorne got the details and implications from Hugh Tunstall-Pedoe of Dundee University.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
By admin | Published:
September 3, 2007
September 3, 2007
Gerald Werner
REFERENCE: Abstract 925, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria
GERALD WERNER, Klinikum Darmstadt, Germany
The ESC congress in Vienna heard that drug eluting stents are highly effective in chronically occluded arteries, when compared with bare metal stents. Derek Thorne got more on this German study from Gerald Werner, of Klinikum Darmstadt in Germany.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
By admin | Published:
September 3, 2007
September 3, 2007
John Cleland
Maarten Simoons
REFERENCE: Hot Line 1 Sunday 11:00 2 Sept, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria
JOHN CLELAND, University of Hull
COMMENT: MAARTEN SIMOONS, Erasmus University, Rotterdam
A new blood test using brain natriuretic peptide or BNP could become the primary step for diagnosing heart failure. This is according to the latest results from the Perindopril for Elderly People with Chronic Heart Failure or PEP-CHF study that measured levels of BNP in heart failure patients who had previously had echocardiograms. It found that many patients had been misdiagnosed. These results suggest that the BNP test should go before the echocardiogram for diagnosing patients with heart failure. Sarah Maxwell discussed the findings with study author John Cleland at the ESC meeting in Vienna.
Maarten Simoons of Erasmus University in Rotterdam commented on the PEP study findings.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
By admin | Published:
September 3, 2007
September 3, 2007
Carlo Di Mario
Eckhart Fleck
REFERENCE: Hot Line II, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria
CARLO DI MARIO, Royal Brompton Hospital, London
COMMENT: ECKART FLECK, Deutsches Herzzentrum Berlin
The CARESS study from Milan and London has shown that for younger, high-risk patients experiencing a myocardial infarction there can be a clear benefit from performing angioplasty as soon as it is available after using lytics with anti-platelet therapy in situations where primary angioplasty is not available. This answers a huge un-met need of what is best to do for patients who are admitted initially to a centre where primary percutaneous intervention is not an immediate option. At the cardiology congress in Vienna Carlo Di Mario told Peter Goodwin that patients at lower risk of bleeding who can proceed to angioplasty should do so.
Eckhart Fleck added his comments about following lytic therapy with angioplasty.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
By admin | Published:
May 14, 2007
May 14, 2007
HARVEY WHITE, Auckland City Hospital, New Zealand
REFERENCE: European Heart Journal Advanced On-Line Publication April 24th, 2007
Enoxaparin could be the new standard anti-thrombotic therapy for patients receiving fibrinolysis for ST elevation myocardial infarction. This finding is from the double-blind EXTRACT-TIMI 25 Trial which compared the low molecular weight heparin with unfractionated heparin and saw a consistent treatment superiority from enoxaparin with a reduction in repeat myocardial infarction and mortality. Sarah Maxwell spoke with the principal investigator Harvey White at the Auckland City Hospital in New Zealand.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
By admin | Published:
May 3, 2007
May 3, 2007
HARVEY WHITE, Auckland City Hospital, New Zealand
REFERENCE: ACUITY Trial, ACC.07 Scientific Session and i2 Innovations Summit. Presentation Number: 2414-5
Patients with acute coronary syndromes who take bivalirudin have fewer major bleeding events and a lower incidence of late stent thrombosis compared with those who receive standard heparin therapy. This is the finding of one year results from the ACUITY study announced by Gregg Stone of Columbia University, New York during the American College of Cardiology annual meeting that took place in New Orleans. Sarah Maxwell asked Harvey White at the Auckland City Hospital in New Zealand to comment about the ACUITY investigation.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
By admin | Published:
April 6, 2007
April 6, 2007
HARVEY WHITE, Auckland City Hospital
REFERENCE: ACC 2007 & N Engl J Med 356: March 2007
The finding from the COURAGE trial: that angioplasty adds no benefits to optimal medical therapy alone for patients with stable coronary disease, should give pause for thought among clinicians all over the world, according to Harvey White, who discussed the new data with Peter Goodwin.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Looking for Atherosclerosis in the Legs Could Save Lives
September 5, 2007
Curt Diehm
CURT DIEHM, University of Heidelberg
Peripheral arterial disease (PAD) can be diagnosed easily by a test using the ankle brachial index (ABI) and its presence can indicate a high risk of myocardial infarction. Curt Diehm explained his findings to Derek Thorne, while Peter Goodwin got expert comment from Freek Verheugt.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.